Related Experiment Video

Updated: Jul 15, 2026

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis

Makoto Wada1, Yutaka Kawahito, Shinya Kimura

  • 1Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

Biochemical and Biophysical Research Communications
|April 17, 2007
PubMed

Insights

Polo-like kinase-1 (PLK-1) is highly expressed in rheumatoid arthritis (RA) synovial tissues, driving synoviocyte proliferation. Targeting PLK-1 with siRNA offers a potential therapeutic strategy for RA treatment.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Rheumatoid arthritis (RA) is characterized by synovial inflammation and hyperplasia.
  • Synoviocytes play a key role in RA pathogenesis and joint destruction.
  • The role of Polo-like kinase-1 (PLK-1) in RA synoviocytes is not well understood.

Purpose of the Study:

  • To investigate the expression and function of PLK-1 in RA synoviocytes.
  • To explore the potential of targeting PLK-1 for RA treatment.

Main Methods:

  • Immunohistochemistry to detect PLK-1 expression in synovial tissues.
  • Western blot analysis to assess PLK-1 expression in cultured synoviocytes.
  • Stimulation of synoviocytes with IL-1beta.
  • siRNA-mediated knockdown of PLK-1.
  • Assessment of synoviocyte proliferation and apoptosis.

Main Results:

  • PLK-1 expression is significantly elevated in synovial tissues of RA patients compared to osteoarthritis and injury.
  • IL-1beta enhances PLK-1 expression and promotes RA synoviocyte proliferation.
  • PLK-1 knockdown using siRNA reduces IL-1beta-induced synoviocyte proliferation and induces apoptosis.
  • PLK-1 is crucial for the proliferation of RA synoviocytes.

Conclusions:

  • PLK-1 is a key regulator of RA synoviocyte proliferation and contributes to RA pathogenesis.
  • Targeting PLK-1 with siRNA demonstrates potential as a therapeutic approach for RA.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...